Quinolones News

#2 December 25, 2006

Levofloxacin remains highly effective against community-acquired Viridans group streptococci

Recent reports describe an increasing number of infections due to antimicrobial-resistant viridans group streptococci and researchers at the Division of Infectious Diseases, Rhode Island Hospital, Providence, RI, have examined 28 community-acquired viridans group streptococci isolates from 27 patients. Although these isolates exhibited different degrees of resistance to a variety of antibiotics, including cefalosporins, macrolides and penicillin, all strains remained 100% susceptible to levofloxacin and vancomycin.

PMID: 17180589

Infection. 2006 Dec;34(6):339-41.

Source : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
pubmed&dopt=Abstract&list_uids=17180589


 
Return to Quinolones News Index


.

  ©1998-2014 BIOMEDIS International, Ltd. All rights reserved. Reproduction in any manner in whole or part prohibited.
Disclaimer
Last updated December 25, 2006